178 related articles for article (PubMed ID: 25922283)
1. Tamoxifen Treatment and the Reduced Risk of Hyperlipidemia in Asian Patients With Breast Cancer: A Population-Based Cohort Study.
Lim YP; Lin CL; Lin YN; Ma WC; Hung DZ; Kao CH
Clin Breast Cancer; 2015 Aug; 15(4):294-300. PubMed ID: 25922283
[TBL] [Abstract][Full Text] [Related]
2. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer.
Sun LM; Chen HJ; Liang JA; Li TC; Kao CH
Br J Cancer; 2014 Oct; 111(9):1836-42. PubMed ID: 25225901
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study.
Sun LM; Chen HJ; Liang JA; Kao CH
QJM; 2016 Feb; 109(2):103-9. PubMed ID: 25852154
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study.
Tzeng HE; Muo CH; Chen HT; Hwang WL; Hsu HC; Tsai CH
BMC Musculoskelet Disord; 2015 May; 16():123. PubMed ID: 25989902
[TBL] [Abstract][Full Text] [Related]
5. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
6. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Hong N; Yoon HG; Seo DH; Park S; Kim SI; Sohn JH; Rhee Y
Eur J Cancer; 2017 Sep; 82():103-114. PubMed ID: 28651157
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen use and acute pancreatitis: A population-based cohort study.
Hsu FG; Hsieh YW; Sheu MJ; Lin CC; Lin CL; Hsu CY; Lee CY; Chang MY; Chang KH
PLoS One; 2017; 12(3):e0173089. PubMed ID: 28291833
[TBL] [Abstract][Full Text] [Related]
8. Risk of contralateral breast cancer after tamoxifen use among Danish women.
Mellemkjær L; Steding-Jessen M; Frederiksen K; Andersson M; Ejlertsen B; Jensen MB; Olsen JH
Ann Epidemiol; 2014 Nov; 24(11):843-8. PubMed ID: 25277504
[TBL] [Abstract][Full Text] [Related]
9. Association of tamoxifen use and reduced cardiovascular events among asian females with breast cancer.
Yang TL; Wu TC; Huang CC; Huang PH; Chung CM; Lin SJ; Chen JW; Chan WL; Chiang CH; Leu HB
Circ J; 2014; 78(1):135-40. PubMed ID: 24107360
[TBL] [Abstract][Full Text] [Related]
10. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study.
Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609
[TBL] [Abstract][Full Text] [Related]
11. The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study.
Hsu WL; Tsai YT; Wu CT; Lai JN
Evid Based Complement Alternat Med; 2015; 2015():385204. PubMed ID: 25815031
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogenic therapy in breast cancer and endometrial modifications.
Mossa B; Marziani R; Hannuna K; Iuele T; Melluso J; Napolitano C
Eur J Gynaecol Oncol; 2005; 26(1):99-102. PubMed ID: 15755012
[TBL] [Abstract][Full Text] [Related]
13. No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen.
Chen TW; Chen HM; Lin CH; Huang CS; Cheng AL; Lai MS; Lu YS
Breast Cancer Res Treat; 2014 Nov; 148(1):135-42. PubMed ID: 25240736
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
Eur J Clin Pharmacol; 2018 Jan; 74(1):99-107. PubMed ID: 28967041
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen citrate for women with unexplained infertility.
Shokeir TA
Arch Gynecol Obstet; 2006 Aug; 274(5):279-83. PubMed ID: 16847636
[TBL] [Abstract][Full Text] [Related]
16. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
17. Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study.
Hu YC; Wu CT; Lai JN; Tsai YT
J Ethnopharmacol; 2015 Jul; 169():356-62. PubMed ID: 25934515
[TBL] [Abstract][Full Text] [Related]
18. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and accompanying hyperlipidemia are independent risk factors for adhesive capsulitis: a nationwide population-based cohort study (version 2).
Lo SF; Chu SW; Muo CH; Meng NH; Chou LW; Huang WC; Huang CM; Sung FC
Rheumatol Int; 2014 Jan; 34(1):67-74. PubMed ID: 23949624
[TBL] [Abstract][Full Text] [Related]
20. Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis.
Zheng Q; Xu F; Nie M; Xia W; Qin T; Qin G; An X; Xue C; Peng R; Yuan Z; Shi Y; Wang S
Medicine (Baltimore); 2015 Oct; 94(40):e1718. PubMed ID: 26448028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
